You are here

Article Text

Article menu
Download PDFPDF
DTB select
EMA suspends licence for ulipristal acetate for uterine fibroids

Abstract

Every month, DTB scans sources of information on treatments, disease management and other healthcare topics for key items to bring to our readers’ attention and help them keep up to date. To do this, we produce succinct, contextualised summaries of the information concerned.

  • Health Care Quality, Access, and Evaluation
  • Primary Health Care

https://doi.org/10.1136/dtb.2020.000022

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors DTB Team.

    • Provenance and peer review Commissioned; internally peer reviewed.